Blog

In this video we speak with Salvador Capella-Gutierrez (Barcelona Supercomputing Center) about the iPC H2020 project. The following questions are discussed: "What is so special of being part of the iPC project?", "What are the most important findings after the...

In this episode, we talk about the iPC project with Pavel Sumazin from Baylor College of Medicine in the USA.

On February 6-9, the Third International Conference on Mathematics and Statistics (AUS-ICMS’20) was hosted by the American University of Sharjah in the United Arab Emirates.

In this video we spoke to Hans Lehrach, scientific lead of the iPC project from the Max-Planck-Gesellschaft. He explains why it is so special to be part of iPC, what are the most important findings after the first year and...

The efficient retrieval and processing of biomedical information from textual sources represents a crucial step to better characterize the molecular entities at play in paediatric cancers.

Find out more about the Technical Meeting in Paris!

Successful treatment of cancer is still a challenge and this is partly due to a wide heterogeneity of cancer composition across patient population.

November has been an exciting dissemination time, as it has brought two conferences that couldn’t be missed

In this video we spoke to Oivier Delattre from the Institut Curie. He explains his part in the iPC H2020 project. He also points out some potential project challenges from his perspective.

Today in a talk with Jolanda Modic about herself and the iPC H2020 project.

For the first time the IGTP has participated in the European Researchers' Night, part of the European Commission's Horizon 2020 Programme, which aims bringing scientists and society together.

In this video we spoke to Natalie Jäger from the German Cancer Research Center. She explains her part in the iPC H2020 project which involves the search of the appropriate data for analysis. She also points out some potential project...

Today in a talk with Diego di Bernardo about himself and the iPC H2020 project.

Find out more about the Technical Meeting in Barcelona!

Find out more about identifying effective personalized medicine for paediatric cancer. Comprehensive computational effort to combine knowledge base, machine-learning, and mechanistic models are used in iPC to predict optimal standards and therapies for personalized treatments.

Today in a talk with María Rodríguez-Martínez - 5 questions about herself and the iPC H2020 project.

Today in a talk with Pavel Sumazin - 5 questions about himself and the iPC H2020 project.

Who are the people of iPC who work every day to fight against paediatric cancer? In our series "Faces of iPC" we call the people working within the project before the curtain. Find out more about their background, their role...

In this video we spoke to Alfonso Valencia from the Barcelona Supercomputing Center. He explains his part in the iPC H2020 project which involves using the power of the supercomputer to analyse biological data. Mr. Valencia also touches on the...

In this video we spoke with Diego di Bernardo from the University of Naples Federico II. about his professional background and some broader aspects of the European Commission funded H2020 iPC project which kicked off in January 2019. He also...

We recently spoke to Maria Rodriguez Martinez from IBM about the European Commission funded H2020 iPC project which kicked off in January 2019. As the technical coordinator, she shared her thoughts on some aspects of iPC including the challenges she...

The iPC project Kick-Off Meeting took place from 15th to 16th January 2019 in Zurich, Switzerland. During those two days, the iPC consortium met at the IBM premises. The first day was dedicated to get to know each other and...

Under the technical leadership of Dr. María Rodríguez Martínez from IBM in Switzerland and the coordination of the Austrian-based private research company Technikon, consortium scientists are committed to a European Commission funded research project entitled individualizedPaediatricCure or iPC. In this...